Home Journals Subjects About My LA Reviewers Authors News Submit
Username: Password:
.
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


Enter the three character code
Visual CAPTCHA
Privacy Statement
 
 
 

Clinical Medicine Insights: Endocrinology and Diabetes

Synopsis: An open access, peer reviewed electronic journal that covers diabetes and endocrine disorders.


Indexing: 6 major databases. Pubmed indexing for NIH-funded research.

Processing time: Decision in 2 weeks for 90% of papers.


Latest news:

Thousands of article downloads per month. 

Click for the latest open access visibility statistics.

View factor:
Journal: 47473
Most read article: 1838
Editor in chief:
Victor Gault
ISSN: 1179-5514


 
 
 





Latest news

 

Read a research profile on author Dr Hiro Koshiyama

Journal newsletter sent to subscribers in week 36, 2009. Register to receive future newsletters. 

Journal newsletter sent to subscribers in week 35, 2009. Register to receive future newsletters. 

Journal newsletter sent to subscribers in week 31, 2009. Register to receive future newsletters. 

The Editor in Chief has issued a new call for papers.  Read it here.

Journal newsletter sent to subscribers in week 24, 2009. Register to receive future newsletters.

This journal is now indexed by Google Scholar. 

Journal newsletter sent to subscribers in week 12, 2009.  Register to receive future newsletters.

This journal has been accepted for indexing in DOAJ.

New call for papers sent to newsletter subscribers in week 8 2009. Readers who wish to be elligible to receive CFPs should subscribe to the newsletter.

Peer reviewers are sought. Click here to apply or to update your details.

Clinical Medicine: Endocrinology and Diabetes has been accepted for indexing in SCOPUS and EMBase




Journal overview

 

Aims and scope:

Clinical Medicine Insights: Endocrinology and Diabetes is an international, open access, peer reviewed journal which considers manuscripts on diabetes and all other disorders of the endocrine system, in addition to related genetic, pathophysiological and epidemiological topics.

Former title:

Prior to 1/1/2010 this journal was titled Clinical Medicine Insights: Endocrinology and Diabetes (ISSN 1178-1173.) 

Editorial standards and procedures:

Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers.  Reviewers are required to provide fair, balanced and constructive reports.  

Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair.  Appeals are considered by the Editor in Chief or Associate Editor.

Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.

Indexing:

This journal is indexed by:

  • Google Scholar
  • CAS
  • Scopus
  • EMBase 
  • DOAJ
  • OAIster

National Institutes of Health Public Access Policy compliant:

As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.

If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf. 




Information for authors

 

Call for papers:

Read the Editor in Chief's latest call for papers here.

Submission types accepted:


Submissions of the following types of manuscripts are accepted:

  • Original research articles.
  • Reviews: comprehensive, authoritative, descriptions of any subject within the journal's scope. They may cover basic science and clinical reviews, ethics, pro/con debates, and equipment reviews.
  • Commentaries: focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue.
  • Hypotheses: articles that present an original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable.
  • Letters to the Editor: these can be either a re-analysis of a previously published article, or a response to such a re-analysis from the authors of the original publication.
  • Methodology articles: these discuss a new experimental method, test or procedure. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested and ideally, but not necessarily, used in a way that proves its value.
  • Short reports: brief reports of data from original research.
  • Meeting reports: a report pertaining to activity at a meeting or conference Articles published in this journal are immediately available without delay upon publication and enjoy substantial visibility.
  • Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. Case reports must meet appropriate ethical standards.

All submissions are subject to prompt, objective and fair peer review in compliance with our Fairness in Peer Review Policy.  Copyright in published articles remains with the author(s).  Authors are continually informed of the progress of their paper and our staff are friendly and responsive. 

One author recently wrote: "I would like to say that this is the most author-friendly editing process I have experienced in over 150 publications. Thank you most sincerely."

Criteria for publication: 

Publication is dependent on peer reviewers' judgement of papers.  Reviewers are asked to provide thoughtful and unbiased feedback to authors to ensure that the conclusions of papers are valid and manuscripts achieve reasonable standards of scholarliness and intelligibility. 

Previous work in the field must be acknowledged and papers should read without unreasonable difficulty.  Papers should fit comfortably within the scope of the journal.

Reviewers are asked to act in a fair, objective and constructive manner which maintains quality standards and helps authors to communicate their research.  They are instructed that in areas of genuinely novel research issues may be raised which cannot immediately be resolved and that absolutely rigorous validation of data may therefore not be possible. 

More information on the role of peer reviewers is available on the information for reviewers page.  Where authors consider that reviewers have made recommendations which are unreasonable, unobjective or ill-founded they may appeal them to the Editor in Chief or Associate Editor under our Fairness in Peer Review Policy.

Articles submitted to other journals:

We are willing to consider papers which have been peer reviewed by other journals but not accepted for publication. 

Services for authors:

Prior to peer review of your paper we can:

  • Have your paper's reference style revised to meet our requirements,
  • Have your paper's English revised by specialist English-speaking technical editors.

After peer review of your paper we can:

  • Have your paper revised in accordance with peer reviewer's recommendations and have a summary of responses to the reviewers created by our specialist external substantive editors,
  • Provide bound reprints of your article in colour or black and white ,
  • Provide online-early rapid publication if your paper prior to typesetting.

What other authors have said:

Libertas Academica actively requests, receives and acts upon feedback from authors, readers and editorial boards.  Here's what some recent authors have said about us:

"Within a couple of days the reviewers had been procured and the manuscript was out."

"The communication between your staff and me has been terrific.  Whenever progress is made with the manuscript, I receive notice.  Quite honestly, I've never had such complete communication with a journal."

"LA is different, and hopefully represents a kind of scientific publication machinery that removes the hurdles from free flow of scientific thought."

Article processing fees:

All submissions to this journal are subject to an article processing fee if they are accepted for publication.  Article processing fees are used to fund the processing of your paper and development of the journal.  Article processing fees are the only compulsory charge you will face and do not vary according to word count, page count, colour figures or any other factor.  There is no additional charge for the author(s) to make any use of their article and no charge to readers to access it.

Full fee waivers are available for authors working in undeveloped nations and partial discounts of 20-50% are available to authors in other nations.  Authors must be able to verifiably demonstrate their suitability for a discount or waiver.  Availability of waivers and discounts is subject to monthly availability and is given at the publisher's discretion.  Waivers and discounts must be applied for prior to submission.  Neither are available after submission.

Register as a peer reviewer:

Do you wish to register as a peer reviewer?  Or are you already a registered peer reviewer but you need to update your contact details?   To register or update your details visit the peer reviewer registration form. 

Applicants must be able to demonstrate at least five years of continuous experience in the journal's subject area including at least two in the previous 24 months.




Editor in Chief profile

 

Dr Victor Gault BSc (Hons) PhD CBiol MIBiol MRSC, is a Lecturer in Molecular Biosciences at the University of Ulster, Coleraine, Northern Ireland, UK. He was awarded his primary degree in Biochemistry at Queen’s University of Belfast and subsequently completed his PhD studies in Diabetes and Endocrinology at Ulster.

His current research focuses on the development and mechanism of action of novel diabetes/obesity therapies based on incretin hormones. Dr Gault holds several patents and has published over 100 peer-reviewed publications and presentations at national and international conferences. He is a member of several professional societies, committees and editorial boards and has received numerous honours and awards for his work to date.

>> Dr Gault's latest call for papers




Editorial Board

 

Alexander I. Agoulnik, PhD
Associate Professor, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX, USA

Nasser Mohammed Al-Daghri, PhD
Assistant Professor, College of Science Biochemistry Department, King Saud University, Riyadh, Kingdom of Saudi Arabia

Yoshimasa Aso, PhD
Associate professor, Department of Internal Medicine, Dokky Medical University, Koshigaya Hospital, Koshigaya, Saitama, Japan

Francisco Castaneda, MD
Molecular Pathobiochemistry and Clinical Research, Max Planck Institute of Molecular Physiology, Dortmund, Germany

Herbert Chen, MD, FACS
Chief, Section of Endocrine Surgery, Department of Surgery, University of Wisconsin, Leader, Endocrine Cancer Disease Group, University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, WI, USA

Michaela Diamant, MD, PhD
Associate Professor of Endocrinology, VU University Medical Center, Diabetes Center / Department of Endocrinology, Amsterdam, The Netherlands

Jodi Anne Flaws, PhD
Professor, Department of Veterinary Biosciences, University of Illinois, Urbana, IL, USA

Mohamad Taghi Goodarzi, PhD
Professor, Dept. of Biochemistry and Nutrition , Medical School, Hamedan University of Medical Sciences, Hamedan, Iran

Robert Hardy, PhD
Associate Professor, Pathology, University of Alabama at Birmingham, Birmingham, AL, USA

Sergio Huerta, MD
Assistant Professor, University of Texas Southwestern Medical Center, Department of Surgery, Dallas, Texas, USA

Serge A Jabbour, PhD
Clinical Associate Professor of Medicine, Division of Endocrinology, Dept of Medicine, Jefferson Medical College, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA

Abba J. Kastin, MD
Professor and Endowed Chair, Pennington Biomedical Research Center, Blood-Brain Barrier Lab, Baton Rouge, LA, USA

Hiroyuki Koshiyama, MD, PhD
Director, Center for Diabetes & Endocrinology, Chairman, Resident Trainging Program Committee, and Director,
Laboratory for Diabetes & Digetive & Kidney Diseases (KLDDK), Tazuke Kofukai Medical Research Institute, Kitano Hospital, and Clinical Professor, Department of Diabetes & Clinical Nutrition, Graduate School of Medicine, Kyoto University, Japan

Gail B. Mahady, PhD
Associate Professor, Director, Clinical Pharmacognosy Laboratory Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy PAHO/WHO Collaborating Centre for Traditional Medicine Dept. Pharmacy Practice, Chicago, IL, USA

Michelle A Miller, MD
Associate Professor of Biochemical Medicine, Clinical Sciences, Warwick Medical School, University of Warwick, Coventry, Warwickshire, United Kingdom

Tiago Jorge Taborda Prazeres Moreira, MD, PhD
Research Assistant, Department of Physiology, University of Lausanne (UNIL), Lausanne, Switzerland

Weihong Pan, PhD
Professor, Division of Neuroscience, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, USA

Ambady Ramachandran, MD
Professor, Chairman / Managing Director, Dr. A. Ramachandran's Diabetes Hospitals, President, India Diabetes Research Foundation, Tamilnadu, India

Allam Appa Rao, PhD
Professor, Department of Computer Science and Systems Engineering, Andhra University College of Engineering (Autonomous), Visakhapatnam, Andhra Pradesh, India

Robert T. Rubin, MD, PhD
Chief, Department of Psychiatry and Mental Health, VA Greater Los Angeles Healthcare System
Professor and Vice Chair, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Jagdish Narain Sharma, PhD
Full Professor, Department of Applied Therapeutics, Faculty of Pharmacy, Health Sciences Centre, Kuwait University, Safat, Kuwait

Jian Shen, PhD
Professor, Department of Pharmacy, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu Province, China

Enrique Soto-Pedre, MD, MSc (epid), MPH
Applied Epidemiology, European Innovative Biomedicine Institute (Eibi), Castro-Urdiales, Cantabria, Spain

Guang Sun, PhD
Associate professor, Discipline of genetics, Faculty of medicine, Memorial University, St. John's, Newfoundland and Labrador, Canada

Hiroyuki Tamemoto, PhD
Assistant professor, Department of Biochemistry, Jichi Medical University, Shimotsuke, Tochigi prefecture, Japan

Carl-Johan Anders Törnhage, PhD
Pediatrician, Neonatologist, Senior doctor, Department of Pediatrics, Central hospital, Skaraborg county, Skövde, Sweden

Curtis Triplitt, PharmD, CDE
Texas Diabetes Institute, Clinical Assistant Professor, Dept. of Medicine, Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

Naveed Younis, MD
Consultant Endocrinologist, Department of Medicine, University Hospital South Manchester NHS Trust, Manchester,United Kingdom

Laura P. Zanello, MD
Assistant Professor, Department of Biochemistry, University of California-Riverside, Riverside, CA, USA

Jin-Rong (Joseph) Zhou, PhD
Assistant Professor of Surgery, Harvard Medical School, Director, Nutrition/Metabolism Laboratory, Beth Israel Deaconess Medical Center, Boston, MA, USA

 

Join an editorial board or update your details:

If you wish to apply to join an editorial board, or if you are already a member and need to update your details, click here.